Antimycobacterial activity of UDP-galactopyranose mutase inhibitors

International Journal of Antimicrobial Agents

Volumn 36, Issue 4, 2010, Pages 364-368

  Borrelli, Silvia ^a   Zandberg, Wesley F ^a   Mohan, Sankar ^a   Ko, Mary ^b   Martinez Gutierrez, Fidel ^b   Partha, Sarathy Karunan ^c   Sanders, David A R ^c   Av Gay, Yossef ^b   Pinto, B Mario ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Mycobacteria; Tuberculosis; UDP galactopyranose mutase inhibitors

Indexed keywords

(4 CHLOROPHENYL) [1 (4 CHLOROPHENYL) 3 HYDROXY 5 METHYL 1H PYRAZOL 4 YL]METHADONE; 3 (4 IODOPHENYL) 2 [4 (3,4 DICHLOROPHENYL)THIAZOL 2 YLAMINO]PROPIONIC ACID; ANTIMYCOBACTERIAL AGENT; ETHAMBUTOL; ISONIAZID; MUTASE; QUININE; RIFAMPICIN; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE DIPHOSPHATE GALACTOPYRANOSE MUTASE; URIDINE DIPHOSPHATE GALACTOPYRANOSE MUTASE INHIBITOR;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; KLEBSIELLA PNEUMONIAE; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING;

ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; CELL LINE; ENZYME INHIBITORS; HUMANS; INTRAMOLECULAR TRANSFERASES; MACROPHAGES; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PHENYLALANINE; PYRAZOLES; THIAZOLES;

EID: 77955924196     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.06.030     Document Type: Article

References (15)

1. Young D.B., Perkins M.D., Duncan K., Barry C.E. Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest 2008, 118:1255-1265.
2. World Health Organization. Global tuberculosis control: surveillance, planning, financing. Geneva, Switzerland: WHO; 2009.
3. Crick D.C., Brennan P.J. Biosynthesis of the arabinogalactan-peptidoglycan complex of Mycobacterium tuberculosis. The mycobacteria cell wall 2008, ASM Press, Washington, DC. M. Daffe, J.-M. Reyrat (Eds.).
4. Pan F., Jackson M., Ma Y.F., McNeil M. Cell wall core galactofuran synthesis is essential for growth of mycobacteria. J Bacteriol 2001, 183:3991-3998. [Erratum in: J Bacteriol 2001;183:6971].
5. Richards M.R., Lowary T.L. Chemistry and biology of galactofuranose-containing polysaccharides. Chembiochem 2009, 10:1920-1938.
6. Tangallapally R.P., Yendapally R., Lee R.E., Hevener K., Jones V.C., Lenaerts A.J.M., et al. Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents. J Med Chem 2004, 47:5276-5283.
7. Dykhuizen E.C., May J.F., Tongpenyai A., Kiessling L.L. Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth. J Am Chem Soc 2008, 130:6706-6707.
8. Castagnolo D., De Logu A., Radi M., Bechi B., Manetti F., Magnani M., et al. Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis. Bioorg Med Chem 2008, 16:8587-8591.
9. Dick T., Lee B.H., Murugasu-Oei B. Oxygen depletion induced dormancy in Mycobacterium smegmatis. FEMS Microbiol Lett 1998, 163:159-164.
10. Pick N., Cameron S., Arad D., Av-Gay Y. Screening of compounds toxicity against human monocytic cell line-THP-1 by flow cytometry. Biol Proced Online 2004, 6:220-225.
11. Partha S.K., van Straaten K.E., Sanders D.A.R. Structural basis of substrate binding to UDP-galactopyranose mutase: crystal structures in the reduced and oxidized state complexed with UDP-galactopyranose and UDP. J Mol Biol 2009, 394:864-877.
12. Carlson E.E., May J.F., Kiessling L.L. Chemical probes of UDP-galactopyranose mutase. Chem Biol 2006, 13:825-837.
13. Feng H.T., Wong N., Wee S., Lee M.M. Simultaneous determination of 19 intracellular nucleotides and nucleotide sugars in Chinese Hamster ovary cells by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci 2008, 870:131-134.
14. National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard. Document M24-A. Wayne, PA: NCCLS; 2003.
15. Hegymegi-Barakonyi B., Szekely R., Varga Z., Kiss R., Borbely G., Nemeth G., et al. Signalling inhibitors against Mycobacterium tuberculosis-early days of a new therapeutic concept in tuberculosis. Curr Med Chem 2008, 15:2760-2770.